User menu

Occupational exposure to cobalt is not associated with incipient signs of dilated cardiomyopathy in a Belgian refinery

Bibliographic reference Lantin, Anne-Catherine ; Vermeulen, Jan ; Mallants, Alex ; Vanoverschelde, Jean-Louis ; Speybroeck, Niko ; et. al. Occupational exposure to cobalt is not associated with incipient signs of dilated cardiomyopathy in a Belgian refinery. In: Occupational and Environmental Medicine : an international peer-reviewed journal in all aspects of occupational & environmental medicine, Vol. 70, no. 6, p. 386-392 (2013)
Permanent URL http://hdl.handle.net/2078.1/132221
  1. Isbister James P, Physiology and pathophysiology of blood volume regulation, 10.1016/s0955-3886(97)00040-4
  2. Alexanderson, 52, 363 (1991)
  3. Raffn E, Mikkelsen Sigurd, Altman D G, Christensen J M, Groth S, Health effects due to occupational exposure to cobalt blue dye among plate painters in a porcelain factory in Denmark., 10.5271/sjweh.1903
  4. Alexandersson, Arbete och Hälsa, 9, 1 (1980)
  5. Rona G., Experimental aspects of cobalt cardiomyopathy, 10.1136/hrt.33.suppl.171
  6. Mohiuddin Syed M., Taskar P.K., Rheault Michel, Roy Paul-E., Chenard Jacques, Morin Yves, Experimental cobalt cardiomyopathy, 10.1016/0002-8703(70)90202-4
  7. Verougstraete Violaine, Mallants Alex, Buchet Jean-Pierre, Swennen Bert, Lison Dominique, Lung Function Changes in Workers Exposed to Cobalt Compounds : A 13-Year Follow-up, 10.1164/rccm.200310-1357oc
  8. ACGIH, TLVs® and BEIs® based on the documentation of the threshold limit values for chemical substances and physical agents and Biological Exposure Indices (2012)
  9. Chahal N. S., Lim T. K., Jain P., Chambers J. C., Kooner J. S., Senior R., Ethnicity-related differences in left ventricular function, structure and geometry: a population study of UK Indian Asian and European white subjects, 10.1136/hrt.2009.173153
  10. BOUSSUGES ALAIN, PINET CHRISTOPHE, MOLENAT FLORENCE, BURNET HENRI, AMBROSI PIERRE, BADIER MONIQUE, SAINTY JEAN-MARIE, OREHEK JEAN, Left Atrial and Ventricular Filling in Chronic Obstructive Pulmonary Disease : An Echocardiographic and Doppler Study, 10.1164/ajrccm.162.2.9908056
  11. Grice H. C., Heggtveit H. A., Wiberg G. S., Van Petten G., Willes R., Experimental cobalt cardiomyopathy: correlation between electrocardiography and pathology, 10.1093/cvr/4.4.452
  12. Cutler D. Joshua, Isner Jeffrey M., Bracey Arthur W., Hufnagel Charles A., Conrad Peter W., Roberts William C., Kerwin Donald M., Weintraub Alan M., Hemochromatosis heart disease: An unemphasized cause of potentially reversible restrictive cardiomyopathy, 10.1016/s0002-9343(80)80020-9
  13. Karnik Ankur A., Fields Anjali V., Shannon Richard P., Diabetic cardiomyopathy, 10.1007/s11906-007-0086-3
  14. Fernandes Verônica Rolim S., Cheng Susan, Lima João A. C., Atherosclerosis imaging and heart failure, 10.1007/s10741-006-0229-7
  15. KLATSKY ARTHUR L., Alcohol and Cardiovascular Diseases, 10.1111/j.1749-6632.2002.tb02901.x
  16. Horowitz, Br J Ind Med, 45, 742 (1988)
  17. Kozdag Guliz, Ural Dilek, Vural Ahmet, Agacdiken Aysen, Kahraman Goksel, Sahin Tayfun, Ural Ertan, Komsuoglu Baki, Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy, 10.1016/j.ejheart.2004.04.016
  18. Arinc Huseyin, Gunduz Huseyin, Tamer Ali, Seyfeli Ergun, Kanat Mustafa, Ozhan Hakan, Akdemir Ramazan, Celebi Harika, Uyan Cihangir, Evaluation of Right Ventricular Function in Patients with Thyroid Dysfunction, 10.1159/000089855
  19. Pluim B. M., Zwinderman A. H., van der Laarse A., van der Wall E. E., The Athlete s Heart : A Meta-Analysis of Cardiac Structure and Function, 10.1161/01.cir.101.3.336
  20. Ristow Bryan, Ali Sadia, Na Beeya, Turakhia Mintu P., Whooley Mary A., Schiller Nelson B., Predicting Heart Failure Hospitalization and Mortality by Quantitative Echocardiography: Is Body Surface Area the Indexing Method of Choice? The Heart and Soul Study, 10.1016/j.echo.2010.01.019
  21. Jafary, J Am Soc Echocardiogr, 783 (2007)
  22. Oldenburg Marcus, Wegner Ralf, Baur Xaver, Severe Cobalt Intoxication Due to Prosthesis Wear in Repeated Total Hip Arthroplasty, 10.1016/j.arth.2008.07.017
  23. Hu Howard, Shih Regina, Rothenberg Stephen, Schwartz Brian S., The Epidemiology of Lead Toxicity in Adults: Measuring Dose and Consideration of Other Methodologic Issues, 10.1289/ehp.9783
  24. Lantin A.-C., Mallants A., Vermeulen J., Speybroeck N., Hoet P., Lison D., Absence of adverse effect on thyroid function and red blood cells in a population of workers exposed to cobalt compounds, 10.1016/j.toxlet.2010.12.003
  25. Swennen, Br J Ind Med, 50, 835 (1993)
  26. Jefferies John Lynn, Towbin Jeffrey A, Dilated cardiomyopathy, 10.1016/s0140-6736(09)62023-7
  27. Seghizzi P., D'Adda F., Borleri D., Barbic F., Mosconi G., Cobalt myocardiopathy. A critical review of literature, 10.1016/0048-9697(94)90135-x
  28. Linna A, Exposure to cobalt in the production of cobalt and cobalt compounds and its effect on the heart, 10.1136/oem.2003.009605
  29. D'Adda F., Borleri D., Migliori M., Mosconi G., Medolago G., Virotta G., Colombo F., Seghizzi P., Cardiac function study in hard metal workers, 10.1016/0048-9697(94)90148-1
  30. Jarvis, J Occup Med, 34, 620 (1992)
  31. Kennedy A., Dornan J.D., King R., FATAL MYOCARDIAL DISEASE ASSOCIATED WITH INDUSTRIAL EXPOSURE TO COBALT, 10.1016/s0140-6736(81)91793-1
  32. Barborik M, Dusek J, Cardiomyopathy accompaning industrial cobalt exposure., 10.1136/hrt.34.1.113
  33. Pehrsson Kenneth, Lins Lars-Eric, COBALT IN URÆMIC CARDIOMYOPATHY, 10.1016/s0140-6736(78)91368-5
  34. Kesteloot, Circulation, 27, 863 (1968)
  35. Morin, Can Med Assoc J, 97, 926 (1967)
  36. McDermott Paul H., Myocardosis and Cardiac Failure in Men, 10.1001/jama.1966.03110160081026
  37. Opie, The heart: physiology, metabolism, pharmacology and therapy (1984)
  38. Fauci, Harrison's principles of internal medicine (2008)
  39. Libby, Braunwald's heart disease. A textbook of cardiovascular medicine (2008)
  40. Murakoshi Nobuyuki, Miyauchi Takashi, Kakinuma Yoshihiko, Yuki Koichi, Goto Katsutoshi, Yamaguchi Iwao, Impairment of Cardiac Energy Metabolism In Vivo Causes Hemodynamic Abnormality and Increases Cardiac Expression of Preproendothelin-1 mRNA : , 10.1097/00005344-200036051-00041
  41. Yamashita Kazuhito, Discher Daryl J., Hu Jing, Bishopric Nanette H., Webster Keith A., Molecular Regulation of the Endothelin-1 Gene by Hypoxia : CONTRIBUTIONS OF HYPOXIA-INDUCIBLE FACTOR-1, ACTIVATOR PROTEIN-1, GATA-2, AND p300/CBP, 10.1074/jbc.m011344200
  42. Hu Jing, Discher Daryl J., Bishopric Nanette H., Webster Keith A., Hypoxia Regulates Expression of the Endothelin-1 Gene through a Proximal Hypoxia-Inducible Factor-1 Binding Site on the Antisense Strand, 10.1006/bbrc.1998.8543
  43. Chen Yiu-Fai, Atrial natriuretic peptide in hypoxia, 10.1016/j.peptides.2004.08.030
  44. Yuan Yong, Hilliard George, Ferguson Tsuneo, Millhorn David E., Cobalt Inhibits the Interaction between Hypoxia-inducible Factor-α and von Hippel-Lindau Protein by Direct Binding to Hypoxia-inducible Factor-α, 10.1074/jbc.m300463200
  45. Steinbrech, Am J Physiol Cell Physiol, 278, 853 (2000)
  46. LISON DOMINIQUE, Cobalt, Handbook on the Toxicology of Metals (2007) ISBN:9780123694133 p.511-528, 10.1016/b978-012369413-3/50080-x
  47. Gleadle, Am J Physiol Cell Physiol, 268, 1362 (1995)
  48. CHUN Yang-Sook, HYUN Ju-Yeon, KWAK Yong-Geun, KIM In-San, KIM Chan-Hyung, CHOI Eunjoo, KIM Myung-Suk, PARK Jong-Wan, Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1, 10.1042/bj20021087
  49. Lauwerys R., Lison D., Health risks associated with cobalt exposure — an overview, 10.1016/0048-9697(94)90125-2